Product Information

TRIAMTERENE-HYDROCHLOROTHIAZIDE 75-50 MG TAB is a generic product labeled by Advagen Pharma Ltd., priced at $0.1211 per EA under NDC 72888009501. Its NADAC has been published 186 times since May 3, 2023.

FDA first approved this application on Feb 23, 2022. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

TRIAMTERENE-HYDROCHLOROTHIAZIDE 75-50 MG TAB

Triamterene and Hydrochlorothiazide
$0.1211per EA

Strength

50; 75 mg/1; mg/1

NDC

72888009501

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Effective Date

11/18/2026

Approval Type

Generic (ANDA)

FDA Application

ANDA216211

FDA Approved

2/23/2022

TE Code

AB

On Market Since

2/23/2022

Pharmacological Classes

Decreased Renal K+ Excretion
Increased Diuresis
Increased Diuresis
Potassium-sparing Diuretic
Thiazide Diuretic
Thiazides

Price Statistics

The NADAC for TRIAMTERENE-HYDROCHLOROTHIAZIDE 75-50 MG TAB has been published 186 times since May 3, 2023, and over the history we have for it it has declined 4.0%. The table below summarizes its recorded NADAC range and movement.

Current price$0.1211 per EA
All-time high$0.1330 (Nov 11, 2026)
All-time low$0.0859 (Nov 20, 2024)
52-week high$0.1330
52-week low$0.1115
Median price$0.1150
Average price$0.1145
Largest weekly change-25.0% (Nov 20, 2024)
Weeks tracked186
Tracking sinceMay 3, 2023

Price History

1W

-8.9%

1M

-7.7%

3M

-3.4%

6M

+6.0%

1Y

+5.2%

3Y

+5.3%

5Y

N/A

All

-4.0%

Generic Alternatives

The matcher finds 4 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 1% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of TRIAMTERENE-HYDROCHLOROTHIAZIDE 75-50 MG TAB?

The current National Average Drug Acquisition Cost (NADAC) for TRIAMTERENE-HYDROCHLOROTHIAZIDE 75-50 MG TAB, manufactured by Advagen Pharma Ltd., is $0.1211 per EA (NDC 72888009501), effective Nov 18, 2026.

How has the price of TRIAMTERENE-HYDROCHLOROTHIAZIDE 75-50 MG TAB changed over time?

Over the history we have for it, the NADAC for TRIAMTERENE-HYDROCHLOROTHIAZIDE 75-50 MG TAB has declined 4.0%. It has been tracked across 186 weekly CMS publications since May 3, 2023.

What are the highest and lowest recorded NADAC prices for TRIAMTERENE-HYDROCHLOROTHIAZIDE 75-50 MG TAB?

Since May 3, 2023, the NADAC for TRIAMTERENE-HYDROCHLOROTHIAZIDE 75-50 MG TAB has ranged from a low of $0.0859 (Nov 20, 2024) to a high of $0.1330 (Nov 11, 2026), with a median of $0.1150 per EA.

Are there cheaper alternatives to TRIAMTERENE-HYDROCHLOROTHIAZIDE 75-50 MG TAB?

Yes. 4 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, TRIAMTERENE-HYDROCHLOROTHIAZIDE 75-50 MG TAB, is $0.1199 per EA — about 1% below TRIAMTERENE-HYDROCHLOROTHIAZIDE 75-50 MG TAB.

Who manufactures TRIAMTERENE-HYDROCHLOROTHIAZIDE 75-50 MG TAB?

TRIAMTERENE-HYDROCHLOROTHIAZIDE 75-50 MG TAB (NDC 72888009501) is labeled by Advagen Pharma Ltd., and CMS classifies it as a generic product.